New Key Statistics Module, Z-Score and F-Score
OTCPK:ENDV Key Ratios
| Market Cap $ M | 0.87 |
| Enterprise Value $ M | 7.94 |
| P/E(ttm) | 0.50 |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | 0.005 |
| Beneish M-Score | -34.33 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.97 |
| EV-to-EBITDA | 0.90 |
| PEG | -- |
| Shares Outstanding M | 349.39 |
| Net Margin (%) | 4,912.06 |
| Operating Margin % | -2,070.21 |
| Pre-tax Margin (%) | 4,912.06 |
| Quick Ratio | -- |
| Current Ratio | -- |
| ROA % (ttm) | 699.74 |
| ROE % (ttm) | 10,000.00 |
| ROIC % (ttm) | -13.43 |
| Dividend Yield % | -- |
| Altman Z-Score | -153.39 |
| Piotroski F-Score | 7.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | Y |
| Cash flow > Earnings | N |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | Y |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | Y |
| Higher Asset Turnover y-y | Y |
ENDV Number of Guru Trades
ENDV Volume of Guru Trades
Gurus Latest Trades with OTCPK:ENDV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ENDV is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Endonovo Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:ENDV
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers